- Boston Scientific Corporation, headquartered in Marlborough, Massachusetts, specializes in medical products and equipment, with a strong market position reflected in their 2025 net sales of $20.074 billion, a 19.9% increase from the previous year.
- In January 2026, Boston Scientific announced a definitive agreement to acquire Penumbra, Inc. for approximately $14.5 billion, enhancing its cardiovascular portfolio and expanding into mechanical thrombectomy and neurovascular segments.
- The company serves a diverse range of healthcare providers and hospitals, focusing on innovative solutions for patients with vascular diseases, and aims to leverage Penumbra's established technologies to enhance patient access globally.
- Boston Scientific's ideal buyers include healthcare professionals and hospital administrators seeking advanced medical technologies to improve patient outcomes, particularly in the growing vascular disease market, making it crucial for sales teams to engage with them now.
Boston Scientific's workforce is organized across 12 departments, with Operations leading at 15 employees, followed closely by Engineering with 13. Information Technology comprises 10 employees, while the Executive and Health Services departments each have 7. This distribution indicates a strong emphasis on operational and engineering functions, essential for the medical products and equipment industry, while maintaining a balanced presence in support and administrative roles.
The company's operations are geographically concentrated, with Marlborough, MA housing the largest workforce at 22 employees, followed by Maple Grove, MN with 20. Saint Paul and Minneapolis, both in Minnesota, contribute 11 and 10 employees, respectively. The significant 'Other' category, accounting for 82 employees across various locations, suggests a distributed workforce model that supports operational flexibility and regional market engagement.
